T2* MRI Analysis for Sarcoma

Completed

Conditions studied: Radiotherapy, Magnetic Resonance Imaging, Sarcoma

In brief

T2\* imaging is a method to identify labile iron pools in tumor cells. These iron pools may be linked to better treatment outcomes for specific types of therapy. This is a small pilot study to see if radiation therapy changes the amount of iron in a sarcoma tumor.

Key facts

Study ID

NCT03658343

Run by

Bryan Allen

People needed

8

Starts

2018-09-18

Expected to finish

2022-02-25

Last updated by the study team

2025-02-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• pathologically confirmed Sarcoma, by biopsy or excision
• prescribed radiation therapy as per standard of care
• treatment to begin within 5 weeks after surgery or biopsy
• ECOG 0, 1, or 2
• ability and willingness to provide informed consent

You may not qualify if…

• < 18 years of age

Where it is running

• Holden Comprehensive Cancer Center — Iowa City, Iowa, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.